Sur ce site

Sur le Web du CNRS

  • Trombinoscope

    Accès restreint

  • Accueil du site >

    The team

    par Sylvie Julien - 12 novembre 2015

    Minibios of lab members :

    Caroline Goujon (CR1 INSERM)

    Caroline did her PhD at the Ecole Normale Supérieure of Lyon, in Jean-Luc Darlix’s laboratory (Inserm U412/U758), under the supervision of Andrea Cimarelli. She studied the restriction of HIV-1 infection in human dendritic cells and discovered that HIV-2/SIV Vpx was able to relieve this block. She then did a long postdoc in Prof. Michael Malim’s laboratory at King’s College London (Feb. 2008-Dec. 2014), where she studied the relationships between HIV-1 and the interferon system. She notably identified human MX2 as one of the major interferon-stimulated genes preventing HIV-1 infection. In 2014, she was awarded the Andy Kaplan prize, an INSERM researcher (CR1) permanent position and an ATIP-Avenir grant to move back to France and start her own group at the CPBS institute in Montpellier.

    Olivier Moncorgé (ANRS-funded postdoc)

    After working as the molecular biology group leader in a French biotech company (Aptanomics SA, Lyon) and as an engineer on HIV-1 translation at the Ecole Normale Supérieure of Lyon, Olivier did his PhD and a 2-year postdoc in Prof. Wendy Barclay’s laboratory, at Imperial College London. Olivier worked on the molecular basis of host range restriction of avian influenza polymerases in mammalian hosts. During his first post-doc, Olivier was part of the European consortium ANTIFLU, aiming at identifying new inhibitors of influenza virus replication. Olivier also studied MX1 protein activity against influenza A virus.

    Rémi Planès (Sidaction-funded postdoc)

    Rémi did his PhD in Toulouse (INSERM U1043, CHU Purpan), under the supervision of Prof. E. Bahraoui. His thesis unravelled the role of HIV-1 Tat protein in TLR4 signalling. Rémi was then awarded a 1-year FRM fellowship to join Dr P. Guermonprez at the Centre for Molecular and Cellular Biology of Inflammation (CMCBI), King’s College London, where he studied the response of human dendritic cells to Plasmodium falciparum-infected red cells. Rémi was recently awarded a 2 year-fellowship by Sidaction to join the Interferon and antiviral restriction Lab and study the physiological role of MX2 and its potential involvement in innate immune signalling.

    Directeur de la Publication : J.M. Mesnard - Comité Editorial : S. Kohler, P. Diamante,